Andres G A, Accinni L, Hsu K C, Penn I, Porter K A, Rendall J M, Seegal B C, Starzl T E
Lab Invest. 1970 Jun;22(6):588-604.
Tissues obtained from 34 human renal allografts by biopsy, 1 to 31 months after transplantation, were studied by histologic, immunofluorescence, and immunoferritin techniques. Our purpose was to gain more precise information concerning the localization of immunoglobulins and complement in glomeruli and to describe the associated tubular and vascular changes. 1. Localization of fluorescein-labeled antibodies (Fl-Abs) to IgG, IgM, 1C, and C′1q was seen in glomeruli from 25 allografts and showed the following distribution of patterns: (a) diffuse linear, four; (b) diffuse granular, four; (c) focal linear, six; (d) focal granular, six; and (e) indeterminate, five. Ferritin-conjugated antibodies (Fer-Abs) localized in 21 allografts. Electron microscopic findings correlated with the foregoing immunofluorescence patterns. (a) Fer-Abs were bound on the endothelial side of the glomerular basement membrane and in the subendothelial space. (b) Fer-Abs were bound in subendothelial and subepithelial deposits similar to those seen in experimental acute or chronic serum sickness. (c and d) Fer-Abs were seen in the subendothelial space and mesangial matrix. Deposits were present in these areas and some bound Fer-Abs. The two groups were not readily separable on the basis of immunopathologic data. (e) Fer-Abs were mostly seen in the mesangial area. 2. Nine allografts displaying little or no binding of Fl-Abs failed to bind Fer-Abs. 3. Small amounts of fibrinogen were found in only six allografts, three of which showed diffuse granular fluorescence. 4. In 12 allografts either Fl-Abs or Fer-Abs or both were bound in walls of blood vessels. The position of these reactants was in foreign deposits and in basement membranes of arteries and veins. The immunopathologic findings seem to support best the hypothesis that damage to allografts is associated with deposition, in glomerular and vascular structures, of circulating antigen-antibody complexes which might contain, in part, transplantation antigens.
对34例人类同种异体肾移植患者在移植后1至31个月通过活检获取的组织进行了组织学、免疫荧光和免疫铁蛋白技术研究。我们的目的是获取关于免疫球蛋白和补体在肾小球中定位的更精确信息,并描述相关的肾小管和血管变化。1. 在25例同种异体移植的肾小球中观察到荧光素标记抗体(Fl-Abs)对IgG、IgM、1C和C′1q的定位,并呈现出以下分布模式:(a)弥漫性线性,4例;(b)弥漫性颗粒状,4例;(c)局灶性线性,6例;(d)局灶性颗粒状,6例;(e)不确定,5例。铁蛋白结合抗体(Fer-Abs)在21例同种异体移植中定位。电子显微镜检查结果与上述免疫荧光模式相关。(a)Fer-Abs结合在肾小球基底膜的内皮侧和内皮下间隙。(b)Fer-Abs结合在内皮下和上皮下沉积物中,类似于实验性急性或慢性血清病中所见。(c和d)Fer-Abs见于内皮下间隙和系膜基质。这些区域有沉积物,一些结合了Fer-Abs。根据免疫病理学数据,这两组不易区分。(e)Fer-Abs主要见于系膜区。2. 9例显示Fl-Abs几乎没有或没有结合的同种异体移植未能结合Fer-Abs。3. 仅在6例同种异体移植中发现少量纤维蛋白原,其中3例显示弥漫性颗粒状荧光。4. 在12例同种异体移植中,Fl-Abs或Fer-Abs或两者都结合在血管壁上。这些反应物的位置在外来沉积物以及动脉和静脉的基底膜中。免疫病理学发现似乎最支持这样的假设,即同种异体移植的损伤与循环抗原-抗体复合物在肾小球和血管结构中的沉积有关,这些复合物可能部分包含移植抗原。